Immediate Implant Placement With Platlet Rich Fibrin as Space Filling Material Versus the Use of Deprotienized Bovine Bone (Tutogen) in Maxillary Premolars.

Immediate Dental Implant Clinical Trial

Official title:

Immediate Implant Placement With Platlet Rich Fibrin as Space Filling Material Versus the Use of Deprotienized Bovine Bone (Tutogen) in Maxillary Premolars. A Randomized Controlled Clinical Trial

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03183349
• Other study ID #: cebc.Cairouni
• Status: Active, not recruiting
• Phase: N/A
• First received: June 6, 2017
• Last updated: June 10, 2017
• Start date: July 2016
• Est. completion date: July 2017

Study information

• Verified date: June 2017
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

20 subjects suffering from non restorable maxillary premolar teeth will be randomly devided into two groups. the selected teeth will be extracted and immeiate implants will be placed in all subjects. the first group will recieve deprotienized bovine bone (tutogen) to fill the buccal space between the implant and the bone, the second group will recieve platlet rich fibrin to fill the buccal space between the implant and the bone

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 20
• Est. completion date: July 2017
• Est. primary completion date: June 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• non restorable maxillary premolars non smoker free from any systemic disease or medication that could impair normal bone healing

Exclusion Criteria:

• any systemic disease that could affect bone healing patient with lesion related to the surgical site

Related Conditions & MeSH terms

• Immediate Dental Implant

Intervention

Procedure:
• deprotienized bovine bone (tutogen)

• platelet rich fibrin

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient morbidity	patient pain level on pain scale using pain chart	14 days
Secondary	crestal bone loss	radiographic analysis computing amount of crestal bone loss around implants using cone beam computed tomography	3 months
Secondary	implants stability quotient	implant stability measured using resonance frequency analysis	3 months